| Nome |
# |
|
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen, file e291c0d4-6e22-cddb-e053-3a05fe0aa144
|
830
|
|
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses, file e291c0d9-013b-cddb-e053-3a05fe0aa144
|
711
|
|
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection., file e291c0d5-6785-cddb-e053-3a05fe0aa144
|
693
|
|
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens., file e291c0d3-acbf-cddb-e053-3a05fe0aa144
|
590
|
|
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase, file e291c0d3-ad50-cddb-e053-3a05fe0aa144
|
434
|
|
Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008, file e291c0d3-af61-cddb-e053-3a05fe0aa144
|
418
|
|
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro, file e291c0d3-ac8b-cddb-e053-3a05fe0aa144
|
411
|
|
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group, file e291c0d3-af07-cddb-e053-3a05fe0aa144
|
396
|
|
HIV-2 A-subtype gp125(C2-V3-C3) mutations and their association with CCR5 and CXCR4 tropism., file e291c0d3-a791-cddb-e053-3a05fe0aa144
|
372
|
|
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: New therapeutic strategies, file e291c0d3-ad38-cddb-e053-3a05fe0aa144
|
359
|
|
Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage, file e291c0d4-5919-cddb-e053-3a05fe0aa144
|
335
|
|
Selected Amino Acid Mutations in HIV-1 B Subtype gp41 are Associated with Specific gp120v3 Signatures in the Regulation of Co-Receptor Usage, file e291c0d3-ae0c-cddb-e053-3a05fe0aa144
|
298
|
|
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance, file e291c0d3-9f86-cddb-e053-3a05fe0aa144
|
289
|
|
The role of HIV infection in neurologic injury, file e291c0d6-8baa-cddb-e053-3a05fe0aa144
|
274
|
|
Highlights on HIV eradication in 2013, file e291c0d4-964d-cddb-e053-3a05fe0aa144
|
251
|
|
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group, file e291c0d4-9660-cddb-e053-3a05fe0aa144
|
250
|
|
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients, file e291c0d5-573d-cddb-e053-3a05fe0aa144
|
240
|
|
Impact of pre-therapy viral load on virological response to modern first-line HAART, file e291c0d5-5604-cddb-e053-3a05fe0aa144
|
236
|
|
'Sentinel' mutations in standard population sequencing can predict the presence
of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep
pyrosequencing, file e291c0d3-ad19-cddb-e053-3a05fe0aa144
|
228
|
|
The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: Evidences from literature, file e291c0d4-95c2-cddb-e053-3a05fe0aa144
|
222
|
|
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage, file e291c0d5-5fa3-cddb-e053-3a05fe0aa144
|
217
|
|
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing, file e291c0d5-5fa5-cddb-e053-3a05fe0aa144
|
187
|
|
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors, file e291c0d4-6394-cddb-e053-3a05fe0aa144
|
172
|
|
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages, file e291c0d4-96f6-cddb-e053-3a05fe0aa144
|
169
|
|
Detecting and understanding genetic and structural features in HIV-1 B subtype V3 underlying HIV-1 co-receptor usage, file e291c0d5-5dec-cddb-e053-3a05fe0aa144
|
165
|
|
The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype, file e291c0d5-5eea-cddb-e053-3a05fe0aa144
|
163
|
|
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART., file e291c0d5-5f98-cddb-e053-3a05fe0aa144
|
150
|
|
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021, file e291c0d9-e833-cddb-e053-3a05fe0aa144
|
140
|
|
Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes, file e291c0d5-5ee1-cddb-e053-3a05fe0aa144
|
130
|
|
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study, file e291c0d6-4d07-cddb-e053-3a05fe0aa144
|
97
|
|
The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion, file e291c0d3-ee2d-cddb-e053-3a05fe0aa144
|
89
|
|
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis, file e291c0d8-8dba-cddb-e053-3a05fe0aa144
|
81
|
|
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile, file 84dab908-161c-49c1-a9ee-ecf983c9f7fe
|
75
|
|
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control, file e291c0d8-ef3e-cddb-e053-3a05fe0aa144
|
62
|
|
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment, file e291c0d9-c15a-cddb-e053-3a05fe0aa144
|
56
|
|
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients, file 882852da-956a-4fdf-8210-cefc3bbe23cf
|
52
|
|
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor, file e291c0d6-4716-cddb-e053-3a05fe0aa144
|
52
|
|
Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence, file e291c0d8-9a36-cddb-e053-3a05fe0aa144
|
48
|
|
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort, file 9ace9a50-261c-49a4-8820-e8968fabe652
|
47
|
|
Effects of amprenavir on HIV-1 maturation, production and infectivity following drug withdrawal in chronically-infected monocytes/macrophages, file e291c0d9-2e3d-cddb-e053-3a05fe0aa144
|
47
|
|
Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection, file 8ba15a7b-c71a-49ec-b246-d0fe91d94764
|
39
|
|
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment, file b297f770-3872-4835-b65a-4d779799edc9
|
38
|
|
An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression, file e291c0d9-c1bf-cddb-e053-3a05fe0aa144
|
29
|
|
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence, file e291c0d3-af5a-cddb-e053-3a05fe0aa144
|
26
|
|
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B, file 79f67a48-43fe-4221-8ad7-4d67c3588b65
|
18
|
|
Editorial: Novel Concepts in Mechanisms Modulating HBV Persistence, Pathogenesis, and Oncogenetic Properties, file 4776eeb3-9612-46f8-aeb8-ae41f9d9a665
|
15
|
|
Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes, file e291c0d5-5ee2-cddb-e053-3a05fe0aa144
|
14
|
|
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages, file 953886e6-d6ff-47ea-9d0b-164a3e6422bd
|
13
|
|
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses, file 32b8fdbc-cc97-4bb2-b323-db5ad2f22570
|
12
|
|
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario?, file 20d753cb-db12-44d6-a4ac-c0b293278e00
|
9
|
|
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels, file e291c0d8-a91f-cddb-e053-3a05fe0aa144
|
6
|
|
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing, file 52761ed5-cb6a-4f94-bf88-6c4213eafea1
|
5
|
|
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies, file eee8a136-d8b3-4808-8c26-4c3c0d0d8331
|
5
|
|
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate + emtricitabine-containing HAART both in vivo and in vitro, file e291c0d6-424a-cddb-e053-3a05fe0aa144
|
4
|
|
New insights into hepatitis B virus lymphotropism: implications for HBV-related lymphomagenesis, file 7e95bb12-888e-47b1-a52c-349d20769702
|
3
|
|
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression, file e291c0d5-e0a7-cddb-e053-3a05fe0aa144
|
3
|
|
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro, file ae3fe82f-0646-4177-8955-960f71b4823c
|
2
|
|
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen, file e291c0d5-9631-cddb-e053-3a05fe0aa144
|
1
|
|
Combined analysis of the prevalence of drug-resistant Hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE), file e291c0d5-d9c1-cddb-e053-3a05fe0aa144
|
1
|
|
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies, file e291c0d6-930c-cddb-e053-3a05fe0aa144
|
1
|
| Totale |
10.280 |